The data continues to come in on the various Covid-19 variants, and so far the news is pretty good, according to BioSpace.

Pfizer Inc. and partner BioNTech Se are developing a booster shot to protect against Covid-19 variants.

AstraZeneca is likely to run an additional global trial to assess the efficacy of the company’s Covid-19 vaccine using a lower dosage, the British drugmaker’s chief executive was quoted as saying amid questions over the results of a late-stage study.

Shares of Gilead Sciences rose following a report that the company was approached by U.K. pharma giant AstraZeneca regarding a potential merger.

As Sanofi continues to undergo a planned renovation announced in December 2019, the company will do so without four long-time executives.

The U.S. Department of Health and Human Services shelved a proposal to drastically cut the level of nicotine in cigarettes, Bloomberg reported citing a regulatory document.

E-cigarette maker Juul Labs Inc.’s revenue is expected to triple during 2019 to about $3.4 billion following a profitable 2018, Bloomberg reported.

Teva Pharmaceutical Industries Ltd. is close to a deal to sell its women’s health assets outside the United States to private equity firm CVC Capital Partners, the Fly reported, citing Bloomberg.